Skip to main content
. 2019 Mar 12;6:23. doi: 10.3389/fnut.2019.00023

Table 1.

HMO compositions in 4-HMO and 25-HMO blends.

No. Compounda Abbreviation Amount in 4-HMO (g/100 g blend) Amount in 25-HMO (g/100 g blend)
1 2′Fucosyllactose 2′FL 61.9 18.7
2 Lacto-N-neo-tetraose LNnT 10.3 7.9
3 Lacto-N-tetraose LNT 14.4 7.9
4 6′Sialyllactose 6′SL 10.3 3.6
5 3-Fucosyllactose 3-FL 12.1
6 Difucosyllactose DF-L 2.7
7 Lacto-N-fucopentaose I LNFP I 6.5
8 Lacto-N-fucopentaose II LNFP II 2.7
9 Lacto-N-fucopentaose III LNFP III 1.8
10 Sialyllacto-N-tetraose a LST a 0.9
11 Sialyllacto-N-neo-tetraose c LST c 2.7
12 3′Sialyllactose 3′SL 3.7
13 Disialyllacto-N-tetraose DSLNT 7.0
14–32 Other oligosaccharidesb 3.1 8.6
Others (mainly salt) 2.9
TOTAL 100.0 100.0

The abundances of each HMO are presented as a relative amount of the total measured area under the curve as determined by High Performance Anion Exchange Chromatography with Pulsed Amperometric Detection (HPAEC-PAD) for each HMO.

a

Compounds 1–13 (90% of all oligosaccharides in the 25-HMO blend).

b

Compounds 14–32 (not quantified).